Progenics Pharmaceuticals
(PGNX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2000 | 12-1999 | 09-1999 | 06-1999 | 03-1999 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | 24,210 | 12,750 | 13,380 | 13,000 |
| Marketable Securities | N/A | 29,650 | 7,860 | 6,720 | 9,010 |
| Receivables | N/A | 1,140 | 3,630 | 1,700 | 2,790 |
| Other current assets | 0 | 1,030 | 590 | 260 | 260 |
| TOTAL | $N/A | $56,030 | $24,830 | $22,060 | $25,060 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | 3,190 | N/A | N/A |
| Investments And Advances | 0 | 13,820 | 2,830 | 2,830 | 1,280 |
| Other Non-Current Assets | 0 | 3 | 3 | 10 | 10 |
| TOTAL | $N/A | $13,823 | $6,023 | $2,840 | $1,290 |
| Total Assets | $N/A | $71,260 | $29,010 | $26,070 | $27,480 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 2,450 | 2,230 | 1,490 | 1,150 |
| Other current liabilities | N/A | 450 | 500 | 500 | 0 |
| TOTAL | $N/A | $2,980 | $2,830 | $2,100 | $1,260 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 410 | 830 | 800 | 0 |
| TOTAL | $N/A | $440 | $870 | $860 | $80 |
| Total Liabilities | $N/A | $3,440 | $3,720 | $2,970 | $1,350 |
| Shareholders' Equity | |||||
| Common Shares | N/A | 10 | 10 | 10 | 10 |
| Retained earnings | N/A | -17,700 | -19,220 | -20,720 | -17,450 |
| Other shareholders' equity | 0 | -820 | -770 | -890 | -980 |
| TOTAL | $N/A | $67,820 | $25,290 | $23,100 | $26,130 |
| Total Liabilities And Equity | $0 | $71,260 | $29,010 | $26,070 | $27,480 |